Clinical trial
Retrospective Safety Study in 12 Months Treatment Nocturia With Minirin Melt in Clinical Practice in Czech Republic
NCT01212224 is registered in ClinicalTrials.gov with Ferring Pharmaceuticals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Retrospective Safety Study in 12 Months Treatment Nocturia With Minirin Melt in Clinical Practice in Czech Republic
- Lead sponsor
- Ferring Pharmaceuticals
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 31, 2010
- Completion date
- December 31, 2013
- Enrollment
- 2,187 (actual)
- Sites
- 81
Conditions
As the registry lists them; a condition with its own page is linked.